Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

What happens when data projects forget the people who use them? A Disconnect. Boehringer Ingelheim turned things around by ...

Gen Z billionaires are here! With some leading their companies while others pursue college degrees or quiet lives, these are ...

The site was created by Boehringer Ingelheim after a survey identified knowledge gaps among owners on many health topics ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

PRNewswire/ -- (Nasdaq: CTSH) and Aker Solutions, a global leader from Norway in the energy industry, have extended their ...

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.

We’re keeping our finger on the pulse and bring you a summary of the latest business updates from the global poultry industry ...

A new study led by Johns Hopkins researchers has identified a significant gap between the number of U.S. patients for whom cholesterol-lowering drugs ...

Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...